We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

WuXi Biologics to Invest in Biologics Manufacturing Facility in Singapore

News   May 24, 2018 | Original story from WuXi

 
WuXi Biologics to Invest in Biologics Manufacturing Facility in Singapore

Dr Chris Chem, CEO, WuXi Biologics

 
 
 

RELATED ARTICLES

A Research Partnership to Find Treatments for Neurological Disorders

News

BioMotiv and Cure Network Dolby Acceleration Partners launch a collaboration to find better treatments for brain disorders.

READ MORE

New 3D-printed Device Could Help Treat Spinal Cord Injuries

News

Researchers hope their neuronal stem cell scaffold could be surgically implanted to help spinal cord injury patients.

READ MORE

Retinoic Acid may Improve Immune Response Against Melanoma

News

Scientists have found a promising strategy to remove one of melanoma’s most powerful defenses, leading to more immune system activity directed at melanoma.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE